obi pharma inc
(4174:R.O.C. OTC Securities Exchange)
obi pharma inc (4174) Snapshot
|
Open
175.00
|
Previous Close
175.29
|
|
|
Day High
175.55
|
Day Low
174.48
|
|
|
52 Week High
02/23/13 - 195.59
|
52 Week Low
12/12/12 - 70.50
|
|
|
Market Cap
24.3B
|
Average Volume 10 Days
283.5K
|
|
|
EPS TTM
-1.95
|
Shares Outstanding
138.3M
|
|
|
EX-Date
--
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
obi pharma inc (4174) Related Businessweek News
No Related Businessweek News Foundobi pharma inc (4174) Details
Optimer Biotechnology, Inc. manufactures anti-infective and immunotherapy drugs such as OPT-822. The company was founded in 2004 and is based in Taipei, Taiwan.
| Recently Viewed | |||
| 4174:TT | 175.48 TWD | +0.19 | |
| Company | Last | Change | |
| No competitor information is available for 4174. | |||
| View Industry Companies | |||
Industry Analysis
4174
Industry Average
| Valuation | 4174 | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | -- | Not Meaningful |
| Price/Book | 28.8x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | -- | Not Meaningful |
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact OBI PHARMA INC, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








